Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: British Journal of Dermatology (2020), 183: 559-563. https://doi.org/10.1111/bjd.18739
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2020
- Urheber
-
Weber, J.
Glutsch, V.
Geissinger, E.
Haug, L.
Lock, J.F.
Schneider, F.
Kneitz, H.
Goebeler, M.
Schilling, B.
Gesierich, A.
- DOI
-
10.1111/bjd.18739
- URN
-
urn:nbn:de:bvb:20-opus-213520
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Weber, J.
- Glutsch, V.
- Geissinger, E.
- Haug, L.
- Lock, J.F.
- Schneider, F.
- Kneitz, H.
- Goebeler, M.
- Schilling, B.
- Gesierich, A.
- Universität Würzburg
Entstanden
- 2020
Ähnliche Objekte (12)
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer
Complete pathological response after neoadjuvant short-course immunotherapy with Ipilimumab and Nivolumab in locally advanced MSI-H/dMMR rectal cancer
Autoimmune radiculoplexus neuropathy under adjuvant nivolumab treatment of a female patient with melanoma
Immunotherapy with tumor antigenspecific T cells in ret transgenic mouse melanoma model
Immunotherapy of malignant melanoma
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
Active specific immunotherapy of malignant melanoma with cytokine gene-transduced tumor cell vaccines
Nivolumab (NSCLC, neoadjuvant) : Addendum zum Projekt A23-74 (Dossierbewertung)
Nivolumab (NSCLC, neoadjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer
Complete pathological response after neoadjuvant short-course immunotherapy with Ipilimumab and Nivolumab in locally advanced MSI-H/dMMR rectal cancer
Autoimmune radiculoplexus neuropathy under adjuvant nivolumab treatment of a female patient with melanoma
Immunotherapy with tumor antigenspecific T cells in ret transgenic mouse melanoma model
Immunotherapy of malignant melanoma
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
Active specific immunotherapy of malignant melanoma with cytokine gene-transduced tumor cell vaccines
Nivolumab (NSCLC, neoadjuvant) : Addendum zum Projekt A23-74 (Dossierbewertung)
Nivolumab (NSCLC, neoadjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
Preoperative (neoadjuvant) chemotherapy : with 49 tables
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer
Complete pathological response after neoadjuvant short-course immunotherapy with Ipilimumab and Nivolumab in locally advanced MSI-H/dMMR rectal cancer
Autoimmune radiculoplexus neuropathy under adjuvant nivolumab treatment of a female patient with melanoma
Immunotherapy with tumor antigenspecific T cells in ret transgenic mouse melanoma model
Immunotherapy of malignant melanoma
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
Active specific immunotherapy of malignant melanoma with cytokine gene-transduced tumor cell vaccines
Nivolumab (NSCLC, neoadjuvant) : Addendum zum Projekt A23-74 (Dossierbewertung)
Nivolumab (NSCLC, neoadjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung